REQUEST A DEMO
Total
USD $0.00
Search more companies

Heni Drugs Pvt Ltd (India)

Main Activities: Plastics Material and Resin Manufacturing
Full name: Heni Drugs Pvt Ltd Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Heni Drugs Pvt Ltd is a company in India, with a head office in Mumbai. The enterprise operates in the Plastics Material and Resin Manufacturing industry. It was first established on February 15, 1993. There are currently 31 (2025) people employed by Heni Drugs Pvt Ltd. The company’s latest financial report indicates a net sales revenue increase of 28.37% in 2025. Its’ total assets recorded a growth of 38.98%. The net profit margin of Heni Drugs Pvt Ltd increased by 1.31% in 2025.

Legal Address
26 Dream Land Vikramnear Shastri Nagar Mulund Colony
Mumbai; Maharashtra; Postal Code: 400082

Contact Details: Purchase the Heni Drugs Pvt Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Heni Drugs Pvt Ltd report to view the information.
Registered Capital:
Purchase the Heni Drugs Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Heni Drugs Pvt Ltd report to view the information.
Incorporation Date:
February 15, 1993
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Heni Drugs Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
28.37%
Total Operating Revenue
28.74%
Operating Profit
17.56%
EBITDA
13.62%
Net Profit/Loss for the Period
76.02%
Total Assets
38.98%
Total Equity
15.23%
Operating Profit Margin
-0.71%
Net Profit Margin
1.31%
Return on Equity (ROE)
4.57%
Debt / Equity
26.08%
Quick Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?